- Report
- April 2025
- 307 Pages
Global
From €4038EUR$4,500USD£3,521GBP
- Report
- January 2026
- 190 Pages
Global
From €3181EUR$3,545USD£2,774GBP
€3534EUR$3,939USD£3,082GBP
- Report
- January 2026
- 188 Pages
Global
From €3181EUR$3,545USD£2,774GBP
€3534EUR$3,939USD£3,082GBP
- Report
- August 2025
- 184 Pages
Global
From €3181EUR$3,545USD£2,774GBP
€3534EUR$3,939USD£3,082GBP
- Report
- August 2025
- 199 Pages
Global
From €3181EUR$3,545USD£2,774GBP
€3534EUR$3,939USD£3,082GBP
- Report
- August 2025
- 189 Pages
Global
From €3181EUR$3,545USD£2,774GBP
€3534EUR$3,939USD£3,082GBP
- Report
- February 2026
- 250 Pages
Global
From €4029EUR$4,490USD£3,513GBP
- Report
- February 2026
- 250 Pages
Global
From €4029EUR$4,490USD£3,513GBP
- Report
- February 2026
- 250 Pages
Global
From €4029EUR$4,490USD£3,513GBP
- Report
- February 2026
- 250 Pages
Global
From €4029EUR$4,490USD£3,513GBP
- Report
- January 2026
- 250 Pages
Global
From €4029EUR$4,490USD£3,513GBP
- Report
- March 2025
- 144 Pages
Global
From €3588EUR$3,999USD£3,129GBP
- Report
- March 2025
- 180 Pages
Global
From €4038EUR$4,500USD£3,521GBP
- Report
- May 2024
- 200 Pages
Global
From €3724EUR$4,150USD£3,247GBP
- Report
- July 2024
- 100 Pages
Global
From €3365EUR$3,750USD£2,934GBP
- Report
- February 2024
- 185 Pages
North America
From €3095EUR$3,450USD£2,700GBP
- Report
- October 2023
- 146 Pages
Middle East, Africa
From €3095EUR$3,450USD£2,700GBP
- Report
- October 2023
- 145 Pages
From €3095EUR$3,450USD£2,700GBP
- Report
- July 2023
- 198 Pages
Europe
From €3095EUR$3,450USD£2,700GBP
- Report
- June 2023
- 184 Pages
Asia Pacific
From €3095EUR$3,450USD£2,700GBP

Yttrium-90 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the treatment of cancer, as well as other diseases, and is produced in nuclear reactors. Yttrium-90 is used in a variety of medical applications, including targeted radiotherapy, radioembolization, and radioimmunotherapy. It is also used in the diagnosis of certain diseases, such as liver cancer.
Yttrium-90 is produced in a variety of forms, including microspheres, nanospheres, and liquid formulations. It is also available in a variety of formulations, including capsules, tablets, and injectables.
The Yttrium-90 market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Nordion, Eckert & Ziegler, IBA Molecular, and Advanced Accelerator Applications. Show Less Read more